[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343562-105":59,"doc-detail-343562-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pycr1-promotes-liver-cancer-cell-growth-and-metastasis-research-article-lactylation-modification","PYCR1 promotes liver cancer cell growth and metastasis - Research article - lactylation modification","","Background: Liver cancer remains among the deadliest cancers worldwide, and current treatments provide limited efficacy. This study investigates pyrroline-5-carboxylate reductase 1 (PYCR1) as a potential therapeutic target by clarifying its role and underlying mechanisms in liver cancer. Methods: Expression analyses, functional assays, transcriptomics, metabolomics, and chromatin immunoprecipitation evaluate growth, metastasis, downstream targets, metabolites, and H3K18 lactylation enrichment at the IRS1 promoter. Results: PYCR1 is elevated in HCC and relates to poor prognosis, while PYCR1 inhibition restrains proliferation and metastasis through IRS1 regulation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pycr1-promotes-liver-cancer-cell-growth-and-metastasis-research-article-lactylation-modification/343562/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pycr1-promotes-liver-cancer-cell-growth-and-metastasis-research-article-lactylation-modification/343562.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of this study on PYCR1 in liver cancer?","Question",{"text":112,"@type":113},"To elucidate the role and underlying mechanisms of PYCR1 in liver cancer and assess it as a potential therapeutic target.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does PYCR1 affect liver cancer cell growth and metastasis?",{"text":117,"@type":113},"PYCR1 knockout/inhibition hinders liver cancer progression by regulating IRS1 expression through lactylation, weakening downstream PI3K/AKT/mTOR and MAPK/ERK pathway activation.",{"name":119,"@type":110,"acceptedAnswer":120},"Which experiments were used to identify PYCR1-related downstream regulators?",{"text":121,"@type":113},"The study uses transcriptome sequencing to search for downstream target genes and metabolomics to identify downstream metabolites, supported by ChIP to analyze H3K18 lactylation enrichment at the IRS1 promoter.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343562,1790291742,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","DOI: 10.1002/ctm2.70045  \nRESEARCH ARTICLE  \nPYCR1 promotes liver cancer cell growth and metastasis by regulating IRS1 expression through lactylation modification  \nHaoyu Wang1 Linpeng Zhou3  \nMu Xu2  Tong Zhang1  Jinkun Pan1  Chaopu Li1  Bei Pan2 Yun Huang1  Chenzi Gao1  Mengping He1  Yao Xue1   \nXuetao Ji1  Xu Zhang1  Ning Wang1  Hongwen Zhou4  Qian Wang1  John Zhong Li1, 5, 6   \n1The Key Laboratory of Rare Metabolic Disease, Department of Biochemistry and Molecular Biology, The Key Laboratory of Human Functional Genomics of Jiangsu Province, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, Jiangsu, China  \n2 Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China  \n3 School of Basic Medicine and Clinical Pharmacy, Nanjing First Hospital, China Pharmaceutical University, Nanjing, Jiangsu, China  \n4 Department of Endocrinology, The First affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China  \n5 Department of Endocrinology, The affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Northern Jiangsu Institute of Clinical Medicine, Huaian, Jiangsu, China  \n6Tianjian Laboratory of Advanced Biomedical Sciences, Institute of Advanced Biomedical Sciences, Zhengzhou University, Zhengzhou, Henan, China  \nGraphical Abstract  \nSchematic diagram illustrating the mechanism by which PYCR1 knockout/inhibition hinders liver cancer (LC) progression by regulating IRS1 expression through lactylation. Upon PYCR1 knockout/inhibition, LC glycolysis is inhibited, and the intracellular lactate level decreases. As a result, the enrichment of H3K18la in the promoter region of IRS1 is lost, leading to a reduction in IRS1 expression. Immediately afterward, the downstream activation of the PI3K/AKT/mTOR and MAPK/ERK pathways was weakened, resulting in a failure to promote the growth and metastasis of LC cells.  \nClin. Transl. Med. 2024;14:e70045 .  \n[https://doi.org/10.1002/ctm2.70045](https://doi.org/10.1002/ctm2.70045)  \n[wileyonlinelibrary.com/journal/ctm2](wileyonlinelibrary.com/journal/ctm2)  \nWANG et al.  \nCorrespondence  \nJohn Zhong Li, The Key Laboratory of Rare Metabolic Disease, Department of Biochemistry and Molecular Biology, The Key Laboratory of Human Functional Genomics of Jiangsu Province, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University 101 Longmian Ave, Jiangning District, Nanjing, Jiangsu, China.  \nEmail: [lizhong@njmu.edu.cn](lizhong@njmu.edu.cn)  \nDOI: 10.1002/ctm2.70045  \nRESEARCH ARTICLE  \nPYCR1 promotes liver cancer cell growth and metastasis by regulating IRS1 expression through lactylation modification  \nHaoyu Wang1 Linpeng Zhou3  \nMu Xu2  Tong Zhang1  Jinkun Pan1  Chaopu Li1  Bei Pan2 Yun Huang1  Chenzi Gao1  Mengping He1  Yao Xue1   \nXuetao Ji1  Xu Zhang1  Ning Wang1  Hongwen Zhou4  Qian Wang1  John Zhong Li1, 5, 6   \n1The Key Laboratory of Rare Metabolic Disease, Department of Biochemistry and Molecular Biology, The Key Laboratory of Human Functional Genomics of Jiangsu Province, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, Jiangsu, China  \n2 Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China  \n3 School of Basic Medicine and Clinical Pharmacy, Nanjing First Hospital, China Pharmaceutical University, Nanjing, Jiangsu, China  \n4 Department of Endocrinology, The First affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China  \n5 Department of Endocrinology, The affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Northern Jiangsu Institute of ","cbCaij0jkE4XtJ8e","https://ap.wps.com/l/cbCaij0jkE4XtJ8e","pdf",15938306,18,"English","# Abstract\n## Background\n## Methods\n## Results","[{\"question\":\"What is the main objective of this study on PYCR1 in liver cancer?\",\"answer\":\"To elucidate the role and underlying mechanisms of PYCR1 in liver cancer and assess it as a potential therapeutic target.\"},{\"question\":\"How does PYCR1 affect liver cancer cell growth and metastasis?\",\"answer\":\"PYCR1 knockout/inhibition hinders liver cancer progression by regulating IRS1 expression through lactylation, weakening downstream PI3K/AKT/mTOR and MAPK/ERK pathway activation.\"},{\"question\":\"Which experiments were used to identify PYCR1-related downstream regulators?\",\"answer\":\"The study uses transcriptome sequencing to search for downstream target genes and metabolomics to identify downstream metabolites, supported by ChIP to analyze H3K18 lactylation enrichment at the IRS1 promoter.\"}]","PYCR1 promotes liver cancer cell growth and metastasis - Research article - lactylation modification | PDF",1790051440,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/66021e26211aa5c36c0e08ab83eb8ef9.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d741aad0a4b1391625f0b2908dcebee.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a6368d60c77029b8a32d065d0598ec50.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be5f6da65c4cb2dee243f794176c3273.webp",980,1287]